Background illustration for clinical trials search

Myasthenia Gravis Clinical Trials

Browse 56 myasthenia gravis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis

for
Myasthenia Gravis, Generalized
Location: Boca Raton FL, Miami FL, Homestead FL, Charleston SC,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18+

Code: NCT07501702

Phase2, Recruiting

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

for
Chronic Inflammatory Demyelinating Polyneuropathy,
Location: New York NY, Montreal, Salt Lake City UT, Seattle WA,
Sponsor: Kite, A Gilead Company

Sex: All

Age: 18 - 70+

Code: NCT07304154

Phase1, Recruiting

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

for
Generalized Myasthenia Gravis
Location: Foxborough MA, New Haven CT, New York NY, Totowa NJ,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT07039916

Phase3, Recruiting

Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod

for
Myasthenia Gravis Crisis, Myasthenia Gravis Exacerbations,
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 18+

Code: NCT06860633

Recruiting

Exercise for Stable Myasthenia Gravis

for
Myasthenia Gravis
Location: Baltimore MD
Sponsor: Baltimore VA Medical Center

Sex: All

Age: 18 - 70

Code: NCT01047761

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

for
Generalized Myasthenia Gravis
Location: Chicago IL
Sponsor: UCB Biopharma SRL

Sex: All

Age: 12 - 17

Code: NCT06055959

Phase2, Phase3, Recruiting

A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)

for
New Onset Generalized Myasthenia Gravis (gMG)
Location: Worcester MA, Boca Raton FL, Miami FL, Orange FL,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT06909214

Recruiting

Seronegative Myasthenia Gravis - Efgartigimod IV

for
Efgartigimod, Generalized Myasthenia Gravis
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06587867

Phase3, Recruiting

Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis

for
Generalized Myasthenia Gravis
Location: Charlottesville VA, Chapel Hill NC, Chicago IL, Calgary,
Sponsor: argenx

Sex: All

Age: 2 - 18

Code: NCT04833894

Phase2, Phase3, Recruiting

A Prospective Natural History and Outcome Measure Validation Study of Congenital Myasthenic Syndromes

for
Myasthenic Syndromes, Congenital
Location: Bethesda MD
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Sex: All

Age: 0 - 70+

Code: NCT06630650

Recruiting

A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4

for
Congenital Myasthenic Syndrome
Location: Boston MA, Philadelphia PA, Ottawa, Columbus OH,
Sponsor: argenx

Sex: All

Age: 2+

Code: NCT06078553

Recruiting

Efgartigimod in IVIG Dependent Myasthenia Gravis Patients

for
Myasthaenia Gravis
Location: Gatineau
Sponsor: Clinique Neuro-Outaouais

Sex: All

Age: 18 - 70+

Code: NCT06765161

Phase3, Recruiting

AXIS MG Patient Registry

for
Myasthenia Gravis (MG), Myasthenia Gravis, Generalized,
Location: Framingham MA
Sponsor: Autoimmune Neurology Alliance

Sex: All

Age: 18+

Code: NCT07761026

Recruiting

MuSK Myasthenia 1000 Study

for
Myasthenia Gravis, MuSK MG, MuSK Myasthenia Gravis
Location: Washington D.C. DC
Sponsor: George Washington University

Sex: All

Age: 7 - 70+

Code: NCT06259071

Recruiting

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

for
Post-Acute COVID-19 Syndrome, ME/CFS, Rheumatic Arthritis,
Location: Delafield WI
Sponsor: Brain Inflammation Collaborative

Sex: All

Age: 2+

Code: NCT04806620

Recruiting

Patients With Congenital Myasthenic Syndrome Will be Treated With Mesenchymal Stem Cell Exosome Solution

for
Congenital Myasthenic Syndrome
Location: Naples FL, Irving TX
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine

Sex: All

Age: 18+

Code: NCT07226726

Phase1, Recruiting